Real-time enrollment status for this metastatic castration-resistant prostate neoplasms clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 4:22 AM UTC
| NCT Number | NCT05818683 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 300 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 13, 2026: Clinical trial NCT05818683 is currently recruiting participants. This phase1 study for metastatic castration-resistant prostate neoplasms is actively seeking new participants at 7 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05818683 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05818683 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.